Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies

[PR Newswire] – INDIANAPOLIS and MAINZ, Germany, May 11, 2015 /PRNewswire/ — Eli Lilly and Company (LLY) and BioNTech AG today announced they have entered into a research collaboration to discover novel cancer . . . → Read More: Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies Similar Articles: Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly Declares Second-Quarter 2015 Dividend Company Update (NYSE:LLY): Lilly to test combinations with Merck, Bristol-Myers’ cancer drugs Company Update: Amgen Inc (NASDAQ:AMGN) – Amgen, Kite Pharma ink deal to develop cancer immunotherapies